Stimuli-Responsive Nanomaterials for Biomedical Applications

被引:414
作者
Blum, Angela P. [1 ]
Kammeyer, Jacquelin K. [1 ]
Rush, Anthony M. [1 ]
Callmann, Cassandra E. [1 ]
Hahn, Michael E. [1 ,2 ]
Gianneschi, Nathan C. [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA
关键词
MESOPOROUS SILICA NANOPARTICLES; RELEASE DRUG-DELIVERY; QUANTUM DOTS; IN-VITRO; MACROMOLECULAR THERAPEUTICS; POLYMER NANOPARTICLES; ENHANCED PERMEABILITY; AUTONOMOUS MOVEMENT; SPHERE TRANSITION; BLOCK-COPOLYMERS;
D O I
10.1021/ja510147n
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nature employs a variety of tactics to precisely time and execute the processes and mechanics of life, relying on sequential sense and response cascades to transduce signaling events over multiple length and time scales. Many of these tactics, such as the activation of a zymogen, involve the direct manipulation of a material by a stimulus. Similarly, effective therapeutics and diagnostics require the selective and efficient homing of material to specific tissues and biomolecular targets with appropriate temporal resolution. These systems must also avoid undesirable or toxic side effects and evade unwanted removal by endogenous clearing mechanisms. Nanoscale delivery vehicles have been developed to package materials with the hope of delivering them to select locations with rates of accumulation and clearance governed by an interplay between the carrier and its cargo. Many modern approaches to drug delivery have taken inspiration from natural activatable materials like zymogens, membrane proteins, and metabolites, whereby stimuli initiate transformations that are required for cargo release, prodrug activation, or selective transport. This Perspective describes key advances in the field of stimuli-responsive nanomaterials while highlighting some of the many challenges faced and opportunities for development. Major hurdles include the increasing need for powerful new tools and strategies for characterizing the dynamics, morphology, and behavior of advanced delivery systems in situ and the perennial problem of identifying truly specific and useful physical or molecular biomarkers that allow a material to autonomously distinguish diseased from normal tissue.
引用
收藏
页码:2140 / 2154
页数:15
相关论文
共 205 条
[51]   Functionalized Ultrasound-Propelled Magnetically Guided Nanomotors: Toward Practical Biomedical Applications [J].
Garcia-Gradilla, Victor ;
Orozco, Jahir ;
Sattayasamitsathit, Sirilak ;
Soto, Fernando ;
Kuralay, Filiz ;
Pourazary, Ashley ;
Katzenberg, Adlai ;
Gao, Wei ;
Shen, Yufeng ;
Wang, Joseph .
ACS NANO, 2013, 7 (10) :9232-9240
[52]   Rod-sphere transition in polybutadiene-poly(L-lysine) block copolymer assemblies [J].
Gebhardt, Kay E. ;
Ahn, Sungsook ;
Venkatachalam, Gopal ;
Savin, Daniel A. .
LANGMUIR, 2007, 23 (05) :2851-2856
[53]   Shape effects of filaments versus spherical particles in flow and drug delivery [J].
Geng, Yan ;
Dalhaimer, Paul ;
Cai, Shenshen ;
Tsai, Richard ;
Tewari, Manorama ;
Minko, Tamara ;
Discher, Dennis E. .
NATURE NANOTECHNOLOGY, 2007, 2 (04) :249-255
[54]   Autonomously motile catalytic nanomotors by bubble propulsion [J].
Gibbs, J. G. ;
Zhao, Y. -P. .
APPLIED PHYSICS LETTERS, 2009, 94 (16)
[55]   Pretargeted Molecular Imaging and Radioimmunotherapy [J].
Goldenberg, David M. ;
Chang, Chien-Hsing ;
Rossi, Edmund A. ;
McBride, William J. ;
Sharkey, Robert M. .
THERANOSTICS, 2012, 2 (05) :523-540
[56]   Pretargeted radioimmunotherapy for B-Cell lymphomas [J].
Green, Damian J. ;
Pagel, John M. ;
Pantelias, Anastasia ;
Hedin, Nathan ;
Lin, Yukang ;
Wilbur, D. Scott ;
Gopal, Ajay ;
Hamlin, Donald K. ;
Press, Oliver W. .
CLINICAL CANCER RESEARCH, 2007, 13 (18) :5598S-5603S
[57]   Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer [J].
Green, M. R. ;
Manikhas, G. M. ;
Orlov, S. ;
Afanasyev, B. ;
Makhson, A. M. ;
Bhar, P. ;
Hawkins, M. J. .
ANNALS OF ONCOLOGY, 2006, 17 (08) :1263-1268
[58]   Macromolecular therapeutics - Advantages and prospects with special emphasis on solid tumour targeting [J].
Greish, K ;
Fang, J ;
Inutsuka, T ;
Nagamitsu, A ;
Maeda, H .
CLINICAL PHARMACOKINETICS, 2003, 42 (13) :1089-1105
[59]  
Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3
[60]   Expansile Nanoparticles: Synthesis, Characterization, and in Vivo Efficacy of an Acid-Responsive Polymeric Drug Delivery System [J].
Griset, Aaron P. ;
Walpole, Joseph ;
Liu, Rong ;
Gaffey, Ann ;
Colson, Yolonda L. ;
Grinstaff, Mark W. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (07) :2469-+